产前晚期早产类固醇:ALPS试验的演变
1Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal-Fetal Medicine, University of California, La Jolla, California.
Clinical obstetrics and gynecology
|April 30, 2024
概括
给晚期早产的母亲服用产前皮质类固醇显著减少了新生儿的呼吸问题. 这一具有里程碑意义的产前晚期类固醇 (ALPS) 试验发现改变了晚期早产婴儿的临床实践.
科学领域:
- 产科和新生儿护理服务
- 临床试验设计和结果.
- 在早产婴儿的呼吸道疾病.
背景情况:
- 晚期早产婴儿 (34-36周怀孕) 面临严重的呼吸风险.
- 对于这个人群来说,呼吸困扰综合征的现有治疗方法是不理想的.
- 产前晚期早产类固醇 (ALPS) 试验是为了弥补这一缺口而启动的.
研究的目的:
- 评估产前皮质类固醇在降低早产晚期婴儿呼吸道疾病的疗效.
- 提供基于证据的指导方针,用于管理有晚期早产风险的怀孕.
主要方法:
- 详细描述产前晚期前期类固醇 (ALPS) 试验设计的详细描述.
- 参与者的纳入/排除标准.
- 呼吸系统发病率的初级和二级结局措施.
主要成果:
- 关于呼吸道结果的主要发现的介绍.
- 对二次结果的分析,包括新生儿重症监护室的入院和入院时间.
- 讨论对美国临床实践的影响.
结论:
- 产前皮质类固醇有效缓解晚期早产婴儿的呼吸道疾病.
- ALPS试验从根本上改变了对于晚期早产的产科实践.
- 长期跟踪数据提供了对干预的持久影响的见解.
更多相关视频
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.3K
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
相关概念视频
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
429
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
429
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
442
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
442